Blockchain: Information
Tracking
AFCEA C4I, George Mason University – 22 May 2018
Sean T Manion PhD
CEO, Science Distributed
Vice President, American College of Military Public Health
My Background
▪ Academia (Neuroscience)
▪ 13 years
▪ Economics, Biochemistry (BS), Psychology, Psychiatry, Neuroscience (PhD)
▪ Temple University, Uniformed Services University of the Health Sciences, DoD, NIH
▪ Government Research Administration (Bureauscience)
▪ 8 years
▪ Deputy Chief of Staff, Research Activities Chief
▪ Defense & Veterans Brain Injury Center, w/ DoD, VA, ED, HHS (NIH, CDC, FDA)
▪ 17 sites, 60+ clinical studies, 100+ clinical researchers, 300+ publications
▪ American College of Military Public Health – Non-profit/Volunteer (Vice President)
▪ Startup – Science Distributed (Platform for Scientists, Blockchain for Trust)
▪ < 1 year (feels like a lot more)
What is a Blockchain?
A Blockchain, a type of distributed ledger technology, is a system of distributed
databases that enables the development of a permanent, tamper proof longitudinal
record, irrefutable audit trail, more sophisticated data queries, and better data
compiling from and data sharing among multiple parties.
It is:
Safe – Encryption plus public and private keys; distributed nature prevents
corruption or physical disruption; no single point of failure
Inexpensive – Distributed across existing system; automatic back-up; automatic
data management via smart contracts; lower maintenance and 3rd party costs
Efficient – Peer-to-peer data exchange; allows for sophisticated data queries;
broader permissioned access to information
3
Blockchain is not bitcoin
▪ Blockchain is multi-purpose type of
platform/system, like Windows OS or
Mac OS
▪ Bitcoin is one application that can be
run on that system
▪ There are an infinite number of
different applications for blockchain
beyond digital currency
4
Blockchain is not hot sauce
▪ “Blockchain isn’t hot sauce, you
can’t just put that s*!t on
everything” – Samson Williams
▪ Blockchain can be overkill in some
applications, and may not be cost
effective to implement.
▪ Blockchain won’t solve problems
with humans (e.g. lack of data
standardization).
6
Image source:
Anca Petre,
http://www.anca
petre.com/
Advantages
▪ Distributive version control: data recorded on a blockchain ledger is extremely
difficult to change or remove as doing so would require changing the record on
many computers
▪ Trust – users establish their identities with one another in a secure, verified way
▪ Transparency
▪ Scaled information sharing
▪ Smart contract execution; data management
▪ Patient/end user will be in control of their data including health data via a data
layer focused secure blockchain digital platform
11
Challenges
▪ Integrating blockchain within existing system
▪ Higher value by integrating end to end and avoiding blockchain silos
▪ Majority/monopoly risk: A majority (not 100%) of ‘nodes’ can confirm that a transaction is valid i.e. matches the
blockchain history - the new transaction will be approved and added to the chain.
▪ Need to develop effective governance models among stakeholders
▪ Blockchain requires new rules of participation and operation, new procedures for decision making and new de-
centralized governance framework
▪ Regulatory development and enforcement
▪ File size limitations, mitigating solutions available (e.g. side chains)
▪ Conflicting commercial interests need to balanced via technology transfer agreements
▪ Lack of maturity of blockchain technology
▪ While technology has constraints, adopting a specific approach helps to selectively implement
▪ Experimental and currently slow because of verifying contracts and cross--‐contract communication
▪ Nascent recognition as legal documentation
▪ Competing platforms
12
Science will be Blockchained by 2025
Sean Manion - Published on January 16, 2017 (LinkedIn Pulse)
https://www.linkedin.com/pulse/science-blockchained-2025-sean-manion
Distributed Science Value Proposition
▪ Better Science (for Scientists)
▪ Problem: Reproducibility Issues
▪ Solution: Improved reproducibility through transparency and immutable audit trail for research data;
better quality data from standardization; improved materials; increased meta-analysis capabilities
▪ Cheaper Research (for Funders)
▪ Problem: Expensive; decreasing ROI
▪ Solution: Increased return on investment for research dollars spent; reduced data management costs
through blockchain/smart contracts, amplified with machine learning/AI
▪ Faster Miracles (for Everyone)
▪ Problem: 17 years from bench to bedside
▪ Solution: Moving more quickly from bench to bedside and improved outcomes with accelerated
research and higher quality data; improved tracking of individual contribution will allow for expanded
permissioned access of data to more brilliant minds for faster findings; assisting with administrative
applications for blockchain (e.g. IRB file process)
U.S. Investments in Medical and Health
Research and Development (2015)
Breakdown by source:
▪ Industry invested more in R&D than any other sector, totaling $102.7 billion.
▪ Federal agencies invested a total of $35.9 billion, with the National Institutes of
Health accounting for $29.6 billion.
▪ Research institutions, including universities and independent research institutes
(IRIs), dedicated more than $12.5 billion to R&D.
▪ Foundations contributed $4.7 billion to U.S. medical and health R&D.
▪ Voluntary health associations, professional societies, and state and local
governments invested nearly $3 billion in medical and health R&D.
U.S. Investments in Medical and Health
Research and Development (2015)
▪ Worldwide $2.5 trillion annually on scientific R&D (data.oecd.org)
▪ Total U.S. medical and health R&D was $158.7 billion.
“U.S. Investments in Medical and Health Research and Development, 2013 – 2015,” Research
America!
▪ !!!!! U.S. biomedical research that can’t be replicated - $28 Billion per year !!!!!!
“Economics of reproducibility in Preclinical Research” Freedman et al, PLoS 13(6) e1002165, 2015
▪ What amount of clinical research can’t be replicated?
https://www.fosteropenscience.eu/
Blockchain
Ecosystem
Blockchain by Industry ($500K+ ICOs 2014 –
Oct 2017; Energy Collective – 135 total):
• Finance – 42%
• Gaming – 13
• Infrastructure – 11
• Media – 9
• Other – 9
• Computer/Storage – 5
• Browser/Social – 4
• Identity/IoT – 3
• Energy – 2
• Healthcare - 2
https://www.coinschedule.com/stats.html
Blockchain
Healthcare
Ecosystem
Key Areas:
• Electronic health record, patient-centric
• Provider identity
• Payments
• Supply chain
• Pharma, Devices
• Clinical trials
Blockchain
Health Science
Research Ecosystem
• Terraforming: Science Distributed
• Legacy: Nature/Digital Science/Katalysis;
Wolfram Alpha (Pluto); IEEE
• Healthcare/Clin Research: Obesity PPM,
Hashed Health, Genomics (Various), etc.
• Other: Atana, Co-Lab, ScienceRoot, Frankl,
Ovium, Peerwith, Scientist.com
• Journal: Blockchain in Healthcare Today;
IEEE; Ledger, Frontiers in Blockchain
Enhancing Federal Research: Traumatic Brain Injury &
Blockchain Technology
By Sean Manion - March 3, 2018
http://www.fedhealthit.com/2018/03/enhancing-federal-research-traumatic-brain-injury-blockchain-technology-part-1-introduction/
Blockchain:
Distributed Science Value Proposition
▪ Better Science (for Scientists)
▪ Problem: Reproducibility Issues
▪ Solution: Improved reproducibility through transparency and immutable audit trail for research data;
better quality data from standardization; improved materials; increased meta-analysis capabilities
▪ Cheaper Research (for Funders)
▪ Problem: Expensive; decreasing ROI
▪ Solution: Increased return on investment for research dollars spent; reduced data management costs
through blockchain/smart contracts, amplified with machine learning/AI
▪ Faster Miracles (for Everyone)
▪ Problem: 17 years from bench to bedside
▪ Solution: Faster from bench to bedside: improved outcomes, accelerated research and higher quality
data; improved tracking of individual researcher contribution will allow for expanded permissioned
access of data; assisting with administrative applications for blockchain (e.g. IRB file process)
Traumatic Brain Injury (TBI): Problem Area
• In 2013, about 2.8 million TBI-related emergency department (ED) visits,
hospitalizations, and deaths occurred in the United States.
• TBI contributed to the deaths of nearly 50,000 people.
• TBI was a diagnosis in more than 282,000 hospitalizations and 2.5 million ED visits. These
consisted of TBI alone or TBI in combination with other injuries.
• In 2012, an estimated 329,290 children (age 19 or younger) were treated in U.S. EDs
for sports and recreation-related injuries that included a diagnosis of concussion or
TBI.
• From 2001 to 2012, the rate of ED visits for sports and recreation-related injuries with a
diagnosis of concussion or TBI, alone or in combination with other injuries, more than
doubled among children (age 19 or younger).
https://www.cdc.gov/traumaticbraininjury/get_the_facts.html
Federal Interagency Traumatic Brain Injury
Research (FITBIR) Informatics System
▪ FITBIR was developed to share data
across the entire TBI research field
▪ Created in Jan 2013 by NIH, DoD
▪ 25 federal agencies partnered: NIH,
DoD, and VA; along with One Mind
▪ Hosted by NIH (fitbir.nih.gov)
▪ Central repository for data
▪ Encourages data sharing, cross-
study comparison, and meta-
analysis
TBI: Federal Research
▪ NIH – 665 active studies; $307 Million (2018, NIH RePORTER)
▪ DoD - ~300 active studies (est.); ~$200 Million annually (est.*)
* “Report to Congress: On Expenditures for Activities on Traumatic Brain Injury and Psychological Health, Including Posttraumatic Stress
Disorder, for Calendar Year 2012”
▪ VA – 171 active studies (2018, NIH RePORTER)
▪ Fed TBI Research – 1,000+ studies; $500+ Million annually
▪ Studies in FITBIR (https://fitbir.nih.gov/content/submitted-data)
▪ 125 studies committed to contribute data
▪ 78 studies submitted some data
▪ 15 studies have made data available of more than 1000 federally funded TBI studies
FITBIR Challenges
▪ Researchers concerned with sharing data; “being scooped”
▪ Limitations with tracking individual researcher contribution
▪ Costly for research groups to format data
▪ Limitations of centralized data quality control
▪ Centralized access to data slow
▪ Identity of requestors
▪ Regulatory approval
▪ Limited number of Common Data Elements (CDE)
▪ CDEs took 5+years to standardize by federal CDE working group
▪ Additional data elements challenging to add/standardize
▪ Limitations of centralized staff to approve new CDEs
How Blockchain Can Help
▪ Expanded data contribution tracking for individual researchers
▪ Auditable record of use of data by other researchers
▪ Data formatting automated by smart contracts
▪ Identity of users verifiable; automated speeding access
▪ Confirmation of regulatory approvals automated
▪ Consensus for additional data elements to facilitate expanded data elements
▪ Consensus for new standards driven by protocol development with experts and
facilitated by automation/smart contracts and assistance by AI analysis of
available literature
General Challenges
for Blockchain in
Federal Research
• Administrators are risk averse
• Regulators are wary of the unknown
• Acquisition standards matter
• Researchers are complex
• Science is a complex system
• Layered incentives; $$ only one
• Want input on protocols
• Developers assume simple, clean data
• Research data is messy, non-standardized
• Research partially centralized/distributed
• Central and single node intermediaries
**Average federal scientist/
administrator perception on
blockchain for research
Next Steps
For Administrators:
▪ Engage health regulators; sandbox approach successful in the UK
▪ Educate key stakeholders on the technology and processes
For Researchers:
▪ Create networks of early adopters
▪ Convene standards committees in key health areas
For Developers:
▪ Use UX design methodology to develop pilot governance protocol
▪ Understand complexities of health and research data
Levels of Evidence for Clinical Practice
Questions – Comments – Future Follow Up
Blockchain Healthcare Situation Report (BC/HC SITREP)
▪ Free weekly newsletter; curated news & events w/ commentary
▪ Email stmanion@gmail.com w/ “BC/HC SITREP” in subject line
Science Distributed Pilot Blockchain – in development
▪ Network, protocol, blockchain; in that order
▪ Email stmanion@gmail.com w/ statement of interest

Blockchain: Information Tracking - Manion AFCEA/GMU C4i

  • 1.
    Blockchain: Information Tracking AFCEA C4I,George Mason University – 22 May 2018 Sean T Manion PhD CEO, Science Distributed Vice President, American College of Military Public Health
  • 2.
    My Background ▪ Academia(Neuroscience) ▪ 13 years ▪ Economics, Biochemistry (BS), Psychology, Psychiatry, Neuroscience (PhD) ▪ Temple University, Uniformed Services University of the Health Sciences, DoD, NIH ▪ Government Research Administration (Bureauscience) ▪ 8 years ▪ Deputy Chief of Staff, Research Activities Chief ▪ Defense & Veterans Brain Injury Center, w/ DoD, VA, ED, HHS (NIH, CDC, FDA) ▪ 17 sites, 60+ clinical studies, 100+ clinical researchers, 300+ publications ▪ American College of Military Public Health – Non-profit/Volunteer (Vice President) ▪ Startup – Science Distributed (Platform for Scientists, Blockchain for Trust) ▪ < 1 year (feels like a lot more)
  • 3.
    What is aBlockchain? A Blockchain, a type of distributed ledger technology, is a system of distributed databases that enables the development of a permanent, tamper proof longitudinal record, irrefutable audit trail, more sophisticated data queries, and better data compiling from and data sharing among multiple parties. It is: Safe – Encryption plus public and private keys; distributed nature prevents corruption or physical disruption; no single point of failure Inexpensive – Distributed across existing system; automatic back-up; automatic data management via smart contracts; lower maintenance and 3rd party costs Efficient – Peer-to-peer data exchange; allows for sophisticated data queries; broader permissioned access to information 3
  • 4.
    Blockchain is notbitcoin ▪ Blockchain is multi-purpose type of platform/system, like Windows OS or Mac OS ▪ Bitcoin is one application that can be run on that system ▪ There are an infinite number of different applications for blockchain beyond digital currency 4
  • 5.
    Blockchain is nothot sauce ▪ “Blockchain isn’t hot sauce, you can’t just put that s*!t on everything” – Samson Williams ▪ Blockchain can be overkill in some applications, and may not be cost effective to implement. ▪ Blockchain won’t solve problems with humans (e.g. lack of data standardization).
  • 6.
  • 10.
  • 11.
    Advantages ▪ Distributive versioncontrol: data recorded on a blockchain ledger is extremely difficult to change or remove as doing so would require changing the record on many computers ▪ Trust – users establish their identities with one another in a secure, verified way ▪ Transparency ▪ Scaled information sharing ▪ Smart contract execution; data management ▪ Patient/end user will be in control of their data including health data via a data layer focused secure blockchain digital platform 11
  • 12.
    Challenges ▪ Integrating blockchainwithin existing system ▪ Higher value by integrating end to end and avoiding blockchain silos ▪ Majority/monopoly risk: A majority (not 100%) of ‘nodes’ can confirm that a transaction is valid i.e. matches the blockchain history - the new transaction will be approved and added to the chain. ▪ Need to develop effective governance models among stakeholders ▪ Blockchain requires new rules of participation and operation, new procedures for decision making and new de- centralized governance framework ▪ Regulatory development and enforcement ▪ File size limitations, mitigating solutions available (e.g. side chains) ▪ Conflicting commercial interests need to balanced via technology transfer agreements ▪ Lack of maturity of blockchain technology ▪ While technology has constraints, adopting a specific approach helps to selectively implement ▪ Experimental and currently slow because of verifying contracts and cross--‐contract communication ▪ Nascent recognition as legal documentation ▪ Competing platforms 12
  • 13.
    Science will beBlockchained by 2025 Sean Manion - Published on January 16, 2017 (LinkedIn Pulse) https://www.linkedin.com/pulse/science-blockchained-2025-sean-manion
  • 14.
    Distributed Science ValueProposition ▪ Better Science (for Scientists) ▪ Problem: Reproducibility Issues ▪ Solution: Improved reproducibility through transparency and immutable audit trail for research data; better quality data from standardization; improved materials; increased meta-analysis capabilities ▪ Cheaper Research (for Funders) ▪ Problem: Expensive; decreasing ROI ▪ Solution: Increased return on investment for research dollars spent; reduced data management costs through blockchain/smart contracts, amplified with machine learning/AI ▪ Faster Miracles (for Everyone) ▪ Problem: 17 years from bench to bedside ▪ Solution: Moving more quickly from bench to bedside and improved outcomes with accelerated research and higher quality data; improved tracking of individual contribution will allow for expanded permissioned access of data to more brilliant minds for faster findings; assisting with administrative applications for blockchain (e.g. IRB file process)
  • 15.
    U.S. Investments inMedical and Health Research and Development (2015) Breakdown by source: ▪ Industry invested more in R&D than any other sector, totaling $102.7 billion. ▪ Federal agencies invested a total of $35.9 billion, with the National Institutes of Health accounting for $29.6 billion. ▪ Research institutions, including universities and independent research institutes (IRIs), dedicated more than $12.5 billion to R&D. ▪ Foundations contributed $4.7 billion to U.S. medical and health R&D. ▪ Voluntary health associations, professional societies, and state and local governments invested nearly $3 billion in medical and health R&D.
  • 16.
    U.S. Investments inMedical and Health Research and Development (2015) ▪ Worldwide $2.5 trillion annually on scientific R&D (data.oecd.org) ▪ Total U.S. medical and health R&D was $158.7 billion. “U.S. Investments in Medical and Health Research and Development, 2013 – 2015,” Research America! ▪ !!!!! U.S. biomedical research that can’t be replicated - $28 Billion per year !!!!!! “Economics of reproducibility in Preclinical Research” Freedman et al, PLoS 13(6) e1002165, 2015 ▪ What amount of clinical research can’t be replicated?
  • 17.
  • 18.
    Blockchain Ecosystem Blockchain by Industry($500K+ ICOs 2014 – Oct 2017; Energy Collective – 135 total): • Finance – 42% • Gaming – 13 • Infrastructure – 11 • Media – 9 • Other – 9 • Computer/Storage – 5 • Browser/Social – 4 • Identity/IoT – 3 • Energy – 2 • Healthcare - 2
  • 19.
  • 20.
    Blockchain Healthcare Ecosystem Key Areas: • Electronichealth record, patient-centric • Provider identity • Payments • Supply chain • Pharma, Devices • Clinical trials
  • 21.
    Blockchain Health Science Research Ecosystem •Terraforming: Science Distributed • Legacy: Nature/Digital Science/Katalysis; Wolfram Alpha (Pluto); IEEE • Healthcare/Clin Research: Obesity PPM, Hashed Health, Genomics (Various), etc. • Other: Atana, Co-Lab, ScienceRoot, Frankl, Ovium, Peerwith, Scientist.com • Journal: Blockchain in Healthcare Today; IEEE; Ledger, Frontiers in Blockchain
  • 22.
    Enhancing Federal Research:Traumatic Brain Injury & Blockchain Technology By Sean Manion - March 3, 2018 http://www.fedhealthit.com/2018/03/enhancing-federal-research-traumatic-brain-injury-blockchain-technology-part-1-introduction/
  • 23.
    Blockchain: Distributed Science ValueProposition ▪ Better Science (for Scientists) ▪ Problem: Reproducibility Issues ▪ Solution: Improved reproducibility through transparency and immutable audit trail for research data; better quality data from standardization; improved materials; increased meta-analysis capabilities ▪ Cheaper Research (for Funders) ▪ Problem: Expensive; decreasing ROI ▪ Solution: Increased return on investment for research dollars spent; reduced data management costs through blockchain/smart contracts, amplified with machine learning/AI ▪ Faster Miracles (for Everyone) ▪ Problem: 17 years from bench to bedside ▪ Solution: Faster from bench to bedside: improved outcomes, accelerated research and higher quality data; improved tracking of individual researcher contribution will allow for expanded permissioned access of data; assisting with administrative applications for blockchain (e.g. IRB file process)
  • 24.
    Traumatic Brain Injury(TBI): Problem Area • In 2013, about 2.8 million TBI-related emergency department (ED) visits, hospitalizations, and deaths occurred in the United States. • TBI contributed to the deaths of nearly 50,000 people. • TBI was a diagnosis in more than 282,000 hospitalizations and 2.5 million ED visits. These consisted of TBI alone or TBI in combination with other injuries. • In 2012, an estimated 329,290 children (age 19 or younger) were treated in U.S. EDs for sports and recreation-related injuries that included a diagnosis of concussion or TBI. • From 2001 to 2012, the rate of ED visits for sports and recreation-related injuries with a diagnosis of concussion or TBI, alone or in combination with other injuries, more than doubled among children (age 19 or younger). https://www.cdc.gov/traumaticbraininjury/get_the_facts.html
  • 25.
    Federal Interagency TraumaticBrain Injury Research (FITBIR) Informatics System ▪ FITBIR was developed to share data across the entire TBI research field ▪ Created in Jan 2013 by NIH, DoD ▪ 25 federal agencies partnered: NIH, DoD, and VA; along with One Mind ▪ Hosted by NIH (fitbir.nih.gov) ▪ Central repository for data ▪ Encourages data sharing, cross- study comparison, and meta- analysis
  • 26.
    TBI: Federal Research ▪NIH – 665 active studies; $307 Million (2018, NIH RePORTER) ▪ DoD - ~300 active studies (est.); ~$200 Million annually (est.*) * “Report to Congress: On Expenditures for Activities on Traumatic Brain Injury and Psychological Health, Including Posttraumatic Stress Disorder, for Calendar Year 2012” ▪ VA – 171 active studies (2018, NIH RePORTER) ▪ Fed TBI Research – 1,000+ studies; $500+ Million annually ▪ Studies in FITBIR (https://fitbir.nih.gov/content/submitted-data) ▪ 125 studies committed to contribute data ▪ 78 studies submitted some data ▪ 15 studies have made data available of more than 1000 federally funded TBI studies
  • 27.
    FITBIR Challenges ▪ Researchersconcerned with sharing data; “being scooped” ▪ Limitations with tracking individual researcher contribution ▪ Costly for research groups to format data ▪ Limitations of centralized data quality control ▪ Centralized access to data slow ▪ Identity of requestors ▪ Regulatory approval ▪ Limited number of Common Data Elements (CDE) ▪ CDEs took 5+years to standardize by federal CDE working group ▪ Additional data elements challenging to add/standardize ▪ Limitations of centralized staff to approve new CDEs
  • 28.
    How Blockchain CanHelp ▪ Expanded data contribution tracking for individual researchers ▪ Auditable record of use of data by other researchers ▪ Data formatting automated by smart contracts ▪ Identity of users verifiable; automated speeding access ▪ Confirmation of regulatory approvals automated ▪ Consensus for additional data elements to facilitate expanded data elements ▪ Consensus for new standards driven by protocol development with experts and facilitated by automation/smart contracts and assistance by AI analysis of available literature
  • 29.
    General Challenges for Blockchainin Federal Research • Administrators are risk averse • Regulators are wary of the unknown • Acquisition standards matter • Researchers are complex • Science is a complex system • Layered incentives; $$ only one • Want input on protocols • Developers assume simple, clean data • Research data is messy, non-standardized • Research partially centralized/distributed • Central and single node intermediaries **Average federal scientist/ administrator perception on blockchain for research
  • 30.
    Next Steps For Administrators: ▪Engage health regulators; sandbox approach successful in the UK ▪ Educate key stakeholders on the technology and processes For Researchers: ▪ Create networks of early adopters ▪ Convene standards committees in key health areas For Developers: ▪ Use UX design methodology to develop pilot governance protocol ▪ Understand complexities of health and research data
  • 31.
    Levels of Evidencefor Clinical Practice
  • 32.
    Questions – Comments– Future Follow Up Blockchain Healthcare Situation Report (BC/HC SITREP) ▪ Free weekly newsletter; curated news & events w/ commentary ▪ Email [email protected] w/ “BC/HC SITREP” in subject line Science Distributed Pilot Blockchain – in development ▪ Network, protocol, blockchain; in that order ▪ Email [email protected] w/ statement of interest